THE UNIVERSITY OF WESTERN ONTARIO
RESEARCH ETHICS BOARD FOR NON-MEDICAL RESEARCH INVOLVING HUMAN
SUBJECTS PROTOCOL SUBMISSION
(VERSION - JANUARY 2002)
The protocol submission form is created in MS Word 97. Be patient with the form –
occasionally some of the boxes do not appear to be fully formed however they are there and
saving the form or the addition of a hard return makes the lines reappear. The question and
response boxes are created in Tables. The sections for narrative responses are outlined in red
and will expand as material is added with the exception of Section 3 where, because the
responses can be lengthy, are to be entered after the question box at the red arrow ⇒. X’s or
other symbols may be used in sections requiring a selection e.g. yes or no. Rows may also
be added to tables 1.5, and 7.1 if required. Once completed, please review the document to
ensure that it is complete and layout (e.g. page breaks and other formatting ) is appropriate.
•
•
Number all pages: The document will automatically number the pages as text is added
(text may be entered directly or copied and pasted from another electronic document) and
the document expands but if hard copy pages from other sources are inserted in the
package they must be numbered appropriately in conjunction with the protocol submission
form. e.g. page 8 a, page 8 b etc.
Bear in mind that some members of the REB may not be experts in your field so please
strive to make your submission understandable to those outside your area of expertise
• Minimum font size is 12 point. Hand written submissions are not acceptable.
It is the investigator’s responsibility to ensure the material is received by the Office of
Research Ethics by the meeting deadline.
Copies: Investigators are expected to provide sufficient copies for the REB review. Submissions
must be collated into packages for each committee member and stapled or clipped with sturdy, well
anchored clips (note – paperclips frequently become dislodged resulting in disordered protocols.)
Instruments –
Fax or email
Instruments –
Recruitment ads or
standard,
Protocol
submissions are
new or adapted
posters
previously
Submission
not accepted.
validated
Full Board
Original
Review
(signed by PI)
4 copies
11 copies
11 copies
+ 10 copies
Incomplete or illegible submissions will be returned to the investigator without review.
Send submissions to: Office of Research Ethics Room 00045 Dental Sciences Building;
The University of Western Ontario London, Ontario N6A 5C1
HAVE ANY
QUESTIONS?
Ethics Officer
Karen Kueneman
Telephone
661-2111 ext. 84588
Email
kueneman@uwo.ca
or
ethics@uwo.ca
FORM 3-F-001 UWO NON-MEDICAL RESEARCH REB SUBMISSION FORM (VERSION – JANUARY 2002)
Page 1
SECTION 1 PROJECT REGISTRATION
1.1
Project Title
Acquisition of French morpho-syntactic structure: a preliminary study.
1.2a
Anticipated Project dates
1.2b
While all protocols are dealt with as quickly as
possible it is helpful to know in advance about
pending agency deadlines. Indicate if there is a
specific funding agency deadline by which REB
approval is required.
1.3
Start Date 01.05.2006
Completion Date 01.06.2006
Pending deadline date
Principal or Lead Investigator at this site. (PI must be a faculty or staff member at UWO or affiliated
institutions. PI for student or resident projects must be the faculty advisor.)
Name
Title & Position
Degrees
Departmental Affiliation
Mailing Address
Telephone
Email
David Heap
Associate Professor
Ph.D
French
French Department, UWO
x85709
Fax
djheap@uwo.ca
1.4
Signature of Local Principal Investigator attesting that:
a) all co-investigators have reviewed the protocol contents and are in agreement with the protocol as
submitted;
b) all investigators have read the Tri-Council Guidelines and the UWO Guidelines on Non-Medical Research
Involving Human Subjects and agree to abide by the guidelines therein;
c) the investigator(s) will adhere to the Protocol and Consent Form as approved by the REB; and
d) the Principal Investigator will notify the REB of any changes or adverse events/experiences in a timely
manner;
e) the study, if funded by an external sponsor, will not start until the contract/ agreement has been approved
by the appropriate university, hospital or research institute official.
______________________________________
Signature
______________
Date
FORM 3-F-001 UWO NON-MEDICAL RESEARCH REB SUBMISSION FORM (VERSION – JANUARY 2002)
Page 2
1.5
List all local co-investigators and collaborators. Include research personnel only if they have a
significant role in the conduct of the study. Expand chart as required.
Name
Title/Position
Degrees
Role
Kanstantsin Tsedryk
Ph.D. Student
B.A, M.A.
Student researcher
Jeff Tennant
Associate Professor
Ph.D.
Thesis co-director
1.6a
1.6b
YES
NO
X
If YES, who is the Principal Investigator or Project Leader for the entire study? Provide name and
contact information.
Is this a multi-centered study?
1.7a
Is this a student project? i.e. Is completion of this project an academic
YES
X
requirement for a course or degree?
NO
1.7b
If YES, please describe the course or degree. (e.g. name of course, Honours BA paper, Masters or
Ph.D theses etc) and the student’s role in the research (e.g. questionnaire design, data collection,
interviews, data analyses etc).
Ph.D. qualifying examination; Student’s role involves questionnaire
design, data collection, and data analyses.
1.8a
What is the status of the funding or support for this
Funding not required
project? The NMREB strongly recommends
waiting to apply for ethics approval until after a
project submitted for funding has received
notification that the funding has been approved.
It is very wasteful of the researcher’s and the
REB’s time to prepare/review a protocol that may
not proceed or may require significant revision
and re-review as a result of receiving less funding
than anticipated.
1.8b
1.8c
1.8d
1.8e
1.8f
Application Pending
Funded
In-Kind contribution only
If Application Pending; Funded; or In-Kind Contribution fill in chart below.
Name of funding agency(s) or
sponsor(s)
Name of investigator
receiving/applying for funding
Date submitted for funding.
Agency/sponsor reference
number if known
Title as submitted to funding
agency(s) if different than title of
this ethics submission
X
FORM 3-F-001 UWO NON-MEDICAL RESEARCH REB SUBMISSION FORM (VERSION – JANUARY 2002)
Page 3
SECTION 3 PROJECT DESCRIPTION
Complete each section under the appropriate heading. Be succinct and adhere to the page limitations. DO NOT
DIRECT THE COMMITTEE TO ‘SEE ATTACHED’. DO NOT USE TEXT COPIED FROM FUNDING
APPLICATIONS OR STUDY PROTOCOLS UNLESS IT PROVIDES A SUCCINCT SUMMARY OF THE
METHODOLOGY APPROPRIATE FOR ETHICAL REVIEW AND DEALS WITH ETHICAL ISSUES. Copies of
detailed proposals submitted to a funding agency or sponsoring agency protocols will not be reviewed as the
ethical issues are not often adequately addressed in such documents and they frequently do not provide a
succinct summary as noted above. Your protocol will be RETURNED UNREVIEWED if the project description
information is incomplete, illegible or improperly filled out.
3.1a
Is this a sequel to previously approved research?
3.1b
If YES, indicate the previous ethics review number(s):
3.1c
If YES, describe differences from the previously approved protocol(s):
YES
NO
X
Provide a brief one or two sentence overview of the proposed research describing the population,
intervention and outcome. E.g. Children 5 to 8 years of age will view a video about animal mothers and
their babies then be asked if they think there are any similarities between an animal mother’s
behaviour and a human mother’s behaviour. The research will take place in the children’s classroom.
University Students studying French as a second language at
different proficiency levels will be asked, firstly, to complete a
questionnaire eliciting their grammaticality judgments of different
uses of object pronouns in French and secondly, to translate
sentences from English into French. The research will take place in
their French class.
3.2
3.4
Background & Justification – Address the scholarly and scientific validity of the study and the
appropriateness of using human subjects. (1 page maximum)
⇒ Since French and English have different features characterizing
personal pronouns, Anglophone learners of French tend to encounter
difficulties in acquiring these grammatical forms in French. By
analyzing learners’ intuitions about and use of pronouns, we seek
to clarify the morphosyntactic status of pronouns in French as a
second language (L2). Through this analysis, we will seek to arrive
at a theoretical representation of their particular behavior on
syntactic and morphological levels in L2. In-depth study of errors
in the use of pronoun clitics in the interlanguage of Anglophone
learners can supply interesting information for theoretical
reflection. In addition, with the knowledge gained through this
analysis, we are interested in addressing practical applications
for the teaching and learning of French as a second language.
3.5
Objectives and Hypotheses: Provide a clear statement of the purpose and objectives of the
project. (1 page maximum)
⇒ The purpose of this study is to investigate learners' intuitive
knowledge of French clitic pronoun structures. More specifically,
FORM 3-F-001 UWO NON-MEDICAL RESEARCH REB SUBMISSION FORM (VERSION – JANUARY 2002)
Page 4
we intend to observe the knowledge that French L2 learners of
different levels of proficiency have of structures that exemplify
categories which are absent in their first language (L1). By
comparing the grammaticality judgments and usage in a translation
task of learners at different stages of acquisition, we hope to
gain a greater understanding of the process learners follow in
acquiring these elements. We will interpret our results in terms
of the answers they suggest to the question of how the status of
“clitic” (i.e. an element that attaches to the verb) develops for
personal pronouns in the interlanguage of Anglophone speakers
learning French. More generally, we are interested in shedding
light through our research on the central theoretical question as
to whether or not learners of an L2 have access to an innate
Universal Grammar (Chomsky 1985) or whether their learning is based
on general cognitive strategies.
3.6
Methodology – Describe the study design and what participants will be asked to do at each stage
of the research. Investigators are encouraged to use flow charts or diagrams in their descriptions.
(2 page maximum)
⇒ In order to investigate learners’ linguistic competence with
respect to L2 French pronoun placement and development of the
pronominal cliticisation, we need a means of determining whether
learners with different proficiency levels unconsciously know that
certain clitic orders and forms are grammatical and that others are
ungrammatical. We have adopted a standard procedure in linguistics
for this purpose: a grammaticality judgment task. Participants will
be asked to judge the grammaticality of 30 phrases where will be
presented different contexts of pronouns use in French. We also
need to examine learners linguistic knowledge through their
performance. For this part of the study, participants will be also
asked to translate 15 phrases from English into the French (see
Appendix B). Control group will complete the grammaticality
judgment test in order to clarify the norm of native speakers.
3.7
Address the strengths and weaknesses of the selected design. Specifically indicate why a
particular design was selected. (1 page maximum)
⇒ In the present research we have chosen a grammaticality judgment
task and a translation task as a means of data elicitation. These
particular designs (standard in the field) allow the researcher to
focus on particular sentence types and to probe specifically for
knowledge of ungrammaticality and use of personal pronouns in
different contexts. This advantage outweighs the possible drawback
that they are not necessarily a perfect reflection of what
learners’ actual performance would be in a situation of spontaneous
speech.
3.8
References – If possible please restrict the list to ten of the most relevant references. References
must contain the author, title of article, journal and page number(s).
Bruhn de Garavito, J. & al.2002. Clitic placement in L2 French:
evidence from sentence matching. Linguistics 38: 487-525.
FORM 3-F-001 UWO NON-MEDICAL RESEARCH REB SUBMISSION FORM (VERSION – JANUARY 2002)
Page 5
Dörnyei, Z. 2003. Questionnaires in second language research :
Construction, administration, and processing. Mahwah, N.J.:
Lawrence Erlbaum Associates.
Ellis, R. & Barkhuizen, G. 2005. Analyzing Learner Language.
Oxford: Oxford University Press.
Granfeldt, J. & S. Schlyter. 2004. Cliticisation in the acquisition
of French as L1 and L2. In The acquisition of French in different
contexts: Focus on functional categories, sous la dir. de P.Prévost
& J. Paradis, p.333-370. Amsterdam: Benjamins.
Herschensohn, J. 2004. Functional categories and the acquisition of
object clitics in L2 French. In The acquisition of French in
different contexts: Focus on functional categories, sous la dir. de
P.Prévost & J. Paradis, p.207-242. Amsterdam: Benjamins.
White, L. 1996. Clitics in L2. In Generative Perspectives on
Language acquisition, sous la dir. Clashen, H., 335-368. Amsterdam:
Benjamins.
3.9
Analysis – Discuss how the data will be analyzed. (1 page maximum)
⇒ Results of Grammaticality judgment test will be coded according
to the different contexts of French pronoun usage and transferred
into the database Excel. Collected data will be statistically
analysed using statistics software SPSS.
Coding system will be applied to the results of Translation Task in
order to transfer them into database and statistically analyse then
using SPSS.
3.10a
3.1b
Researchers are required to propose a continuing review
process appropriate for this project. At a minimum all protocols
will require the completion of the REB’s Surveillance Report
Form annually. Please indicate your recommendation as to the
frequency of the REB’s continuing review.
ANNUALLY
X
(default)
EVERY 6 MONTHS
EVERY 3 MONTHS
EVERY MONTH
If the risks associated with this project are such that they warrant more than an annual review please
discuss what type of report you will provide the REB.
SECTION 4 RESEARCH PARTICIPANTS
Sample Size:
4.1a
Number of subjects in entire study
4.1b
Number of subjects at this centre
4.1c
Number of centres participating
50
50
1
FORM 3-F-001 UWO NON-MEDICAL RESEARCH REB SUBMISSION FORM (VERSION – JANUARY 2002)
Page 6
4.2
For all study types, justify the sample size. If a formal sample size calculation was not used give
a rationale for the proposed number of subjects. If a formal sample size calculation was
performed, complete 4.3 and 4.4.
⇒ We based our decision with respect to the sample size on the
following observation by a research in the field:”The principal
concern is to sample enough learners for the expected results to be
able to reach statistical significance. Because in L2 studies
meaningful correlation reported in journal articles have often been
as low as 0.30 and 0.40. a good rule of thumb is that we need
around 50 participants to make sure that these coefficients are
significant…” Dornyei (2003:74).
4.3
Sample Size Calculation – give the actual calculation
⇒ N/A
4.4
Sample Size Reference:
Give a reference for the formula used. If, instead of a calculation, a table in a published source
was used, provide the reference(s) and table reference numbers. If a sample size calculator was
used, provide a description of the software package used and/or the URL for internet-based
calculators.
⇒ N/A
4.5
The study will involve: (check all that apply)
Incompetent or unconscious participants
Minors (under 18)
Institutionalized persons (e.g. prison, extended care facility)
UWO Psychology Pool
Participants with language barriers (e.g. illiterate, non-English speaking, dysphasic)
Employees or students of UWO or the institution where the study is being carried out
Patients
Pregnant women
Participants recruited in emergency or life-threatening situations
Other (describe)
4.6a
X
X
Will the study involve males AND females?
4.6b
X
YES
NO
If NO, explain why only one gender is being selected. (e.g. condition under study is gender specific)
4.7
What is the age range of the participants?
4.8
Participant Inclusion and Exclusion Criteria: List all inclusion/exclusion criteria and indicate with an
asterisk (*) those criteria which will be included in the Letter of Information.
Inclusion Criteria
4.8a
LOWER AGE LIMIT
UPPER AGE LIMIT
18
65
FORM 3-F-001 UWO NON-MEDICAL RESEARCH REB SUBMISSION FORM (VERSION – JANUARY 2002)
Page 7
University undergraduate students of different levels of proficiency of French.
4.8b
Exclusion Criteria
French is a first language of participant
4.9a
Are these participants also taking part in other research?
YES
NO
UNKNOWN
X
4.9b
If YES or UNKNOWN, explain any risks associated with participation in multiple studies
There are no known risks associated with participation in this study while participating in
another study.
SECTION 5 PARTICIPANT RECRUITMENT
5.1
Describe the method of recruiting and sampling participants.
Participants will be recruited in French intersession courses (French 021, French 271 and
French 381) at Western. The student researcher will contact them in class by prior
arrangement with their class instructors.
5.2
Identify who will be contacting them.
The student researcher will contact the participants.
5.3
Indicate where the research will be conducted.
The research will be conducted in a private office or other quiet room at Western by prior
arrangement with the class instructor and students.
5.4
Will announcements or advertisements be used?
YES
NO
X
If YES (Provide copies of all advertisements /announcements that will be used)
SECTION 6 RESEARCH PROCEDURES
6.1
Indicate which of the following interventions, testing or procedures are to be performed on the human
participants as part of this research study. (Check as many as needed)
Interview/survey/questionnaire X
Evaluation of program or services
Non-invasive physical measurements (e.g. BP,
Cognitive or perceptual experiment
temperature)
Observation of public behaviour
Collection of biological materials
Analysis of existing data
Retrospective chart or file review
Audio or video taping
Other (specify)
FORM 3-F-001 UWO NON-MEDICAL RESEARCH REB SUBMISSION FORM (VERSION – JANUARY 2002)
Page 8
SECTION 7 INSTRUMENTS TO BE USED IN STUDY
Instruments (forms) = questionnaires, assessment forms, scales, interviews, surveys and
diaries etc.
7.1
In the chart below list all instruments that will be used in the study. If you will be using standard,
previously validated or widely accepted instruments provide FOUR copies. If the instruments have
been developed or adapted for this project, provide 10 copies Expand chart as required.
If you are conducting open-ended or unstructured interviews or focus groups provide an outline of the
topics to be discussed.
To assist the REB indicate clearly on this chart, who will be completing the form (E.g. subject – self
administered, subject-interviewed, caregiver, teacher etc)
INSTRUMENT
STATUS
Who will be completing Standard
the form?
New
Adapted
Questionnaire
Subject
New
SECTION 8 DECEPTION OR PARTIAL DISCLOSURE TO BE USED IN THE STUDY
8.1a
8.1b
8.1c
Do any of the procedures in this study include the use of deception or partial
disclosure of information to participants?
If YES, provide a rationale for the planned deception or partial disclosure.
YES
NO
X
If YES, describe the procedures for a) debriefing the participants and b) giving them a second
opportunity to consent to participate after debriefing.
SECTION 9 RISKS AND BENEFITS OF THE RESEARCH
RISKS & DISCOMFORTS: Discuss the overall risks of the proposed research, and specify the
particular risks and discomforts associated with each aspect of the protocol. Consider physical,
psychological, emotional, social, economic etc. risks and stressors.
There are no known risks associated with participation in this research.
9.1
BENEFITS: Discuss any possible direct benefits to the research participants as a result of their
participation in the study. Please note that monetary compensation is not considered a benefit. If
applicable, discuss possible benefits to society at large or the population being studied.
There are no significant direct benefits to research participants as a result of participation in
the study, although the activities might help them in their learning of these elements of
French grammar.
9.2
FORM 3-F-001 UWO NON-MEDICAL RESEARCH REB SUBMISSION FORM (VERSION – JANUARY 2002)
Page 9
SECTION 10 COMPENSATION AND COSTS
10.1a
10.1b
10.2a
10.2b
Will the participants be compensated or reimbursed for their time and
YES
expenses?
NO
X
If YES, provide details. Specify the amount, what the compensation or reimbursement is for, and how
payment will be determined for participants who do not complete the study.
Are the participants likely to incur any additional expenses or inconveniences as
a result of their participation in this study?
If YES, describe
YES
NO
X
SECTION 11 PROTECTION OF HEALTH AND SAFETY OF PARTICIPANTS
11.1
Describe facilities and procedures to protect the physical and mental health, comfort and safety of the
participants.
Not applicable
11.2a
11.2b
YES
Will the study be likely to induce stress, fear, anxiety in some or all participants
or require them to discuss painful memories of past events?
NO
If YES, explain what resources you will make available to subjects to cope with such stress.
X
SECTION 12 INFORMATION ON THE RESEARCH RECORDS
12.1
Describe the procedures to be used to ensure anonymity of participants and for preserving the
confidentiality of data both during the research and in the release of the findings. Describe any
condition in which confidentiality or anonymity cannot be guaranteed or must be breached.
Participants will not be asked to put their name on the questionnaire. Participants will be
identified with a code number only in the database of questionnaire responses and will not
be identified in any reports of the results of the research. Consent forms signed will be kept
separately.
12.2
Describe the procedures for securing and storing written records, videotapes, computer discs,
recordings and questionnaires etc. Describe the method of disposal and indicate the length of time the
material will be retained.
The original questionnaires will be stored in a locked cabinet in the Principal Investigator’s
office for two years, after which time they will be destroyed.
12.3
Identify all agencies or individuals other than the research team who may have access to confidential
data collected for this study, now or in the future e.g. the Sponsor(s), regulatory agencies such as
Health Canada or the FDA etc.
Only the research team has access to confidential data linking participants’ identity to their
responses.
FORM 3-F-001 UWO NON-MEDICAL RESEARCH REB SUBMISSION FORM (VERSION – JANUARY 2002) Page 10
12.4
Briefly describe any plans for provision of feedback to participants.
Participants will be provided with detailed answers for questionnaire and explicit explanation
of correct use of French pronouns in different contexts.
SECTION 13 INFORMED CONSENT DOCUMENTATION
Disclaimer: The REB does not assess the legal validity of the consent form nor does it provide any other legal
advice.
13.1
If written consent cannot be obtained from potential participants prior to intervention or written consent
is not appropriate, provide a justification. (E.g. completion of a questionnaire in a survey study is
evidence of compliance.)
NA
13.2
Attach a copy of the documentation that will be used to inform and obtain consent from the potential
participants about the research. Separate Information/consent documents or a combined
Information/Consent document may be used. Wording regarding the participant’s consent must
comply with the UWO policies and procedures and participants must be given a copy of the Letter of
Information or combined Information/consent document to keep for reference.
Requests for interviews with persons in authority need not follow such a structured
outline. (see Section 10.0 in the Guidelines.)
COMPLETE CHECKLIST ON NEXT PAGE
&
INCLUDE IT WITH YOUR SUBMISSION
FORM 3-F-001 UWO NON-MEDICAL RESEARCH REB SUBMISSION FORM (VERSION – JANUARY 2002) Page 11
13.3
CHECKLIST – INFORMATION & CONSENT DOCUMENTATION
Checklist must be included with the protocol submission.
HAVE YOU INCLUDED OR ADDRESSED THE FOLLOWING ISSUES?
YES
Not
Appl
X
X
X
X
X
X
X
X
X
30 min
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
(see Informed Consent documentation guidelines Appendix 1 NMREB
guidelines for detailed description/requirements of each category)
Title of the research
Identity of researchers & sponsors
Invitation to participate in research
Information/consent documents addressed to research participant
Summary explanation of research
Number of participants – total & local
Participant inclusion & exclusion criteria
Description of the research and any experimental procedures
Explained specific research techniques
Estimate of participant’s time commitment
Location of the research
Described Risks / Harms / Benefits
Explained voluntary participation and freedom to refuse to participate/withdraw at any time.
Participation in concurrent or future studies
Specimens or Human Tissues (separate consent for banking and unspecified future research)
Notification of new findings
Anonymity
Confidentiality
Alternative treatments
Contact person(s) for participants a) regarding the study & b) subject rights
Compensation & Costs to Subjects
No waiver of rights
No indication of institutional or REB approval
Publication of results
Conflict of Interest declared
Measures taken to deal with stress, anxiety, or fear induced by study, if any
Language Level - lay language, grade 8 level
Formatting – pages numbered, type size, page layout, header/footer, headings
Consent Statement as per UWO standard or written consent not required
Signatures – participant, person obtaining consent
what the study is about
Assent form for
children 7+
why the child is eligible to participate for the study
(Optional)
procedures, what will happen
voluntary participation, withdrawal
risks, discomforts
benefits
contacts
an invitation to ask questions
signature
UWO NON-MEDICAL RESEARCH REB SUBMISSION FORM
APPENDIX
Page 13
Appendix A
LETTER OF INFORMATION
Acquisition of French morpho-syntactic structure: a preliminary study.
I am a Ph.D. student in the French Department at The University of Western Ontario and the
information I am collecting will be used in my thesis.
You are being invited to participate in a research study looking at the acquisition of French
as a second language by Anglophone university students.
If you agree to take part in this study, I would like to ask you, firstly, to complete a
questionnaire where we are interested in your judgments about whether particular
sentences are acceptable for you in French or not and, secondly, to translate some
sentences from English into the French. It will take no more than 20-30 minutes of your time
and will take place in a private office or other quiet room at Western.
There are no known risks to your participation in this study.
Participation in this study is voluntary. You may refuse to participate, refuse to answer any
questions or withdraw from the study at any time with no effect on your academic status.
You will not get a personal benefit from participating in this study but your participation may
help us get new knowledge that may benefit future students studying French as second
language at university. Also, if interested, you will be provided with detailed results of your
questionnaire and explanation of correct use of certain structures of French that will help
you to improve your knowledge of this language.
Your research records will be stored in the following manner: locked in a cabinet in a secure
office; only research team will have access to the data and it will be destroyed after 2 years.
If the results of the study are published, your name will not be used and no information that
discloses your identity will be released or published.
The Research Ethics Board at The University of Western Ontario may contact you directly to
ask about your participation in the study.
If you have any questions about the study, you may contact me, Kanstantsin Tsedryk, at
ktsedryk@uwo.ca or Dr. D.Heap at djheap@uwo.ca
If you have questions about your rights as a research subject you may contact the Director
of the Office of Research Ethics, The University of Western Ontario at 519-661-3036 or
ethics@uwo.ca.
You will not be compensated for your participation in this research study.
UWO NON-MEDICAL RESEARCH REB SUBMISSION FORM
APPENDIX
Page 14
CONSENT FORM
Acquisition of French morpho-syntactic structure: a preliminary study.
I have read the Letter of Information, have had the nature of the study explained to me and I
agree to participate. All questions have been answered to my satisfaction.
Date:
Signature of Research Participant:
Name of Participant (Printed):
Signature of Person Obtaining Consent:
Name of Person Obtaining Consent (Printed):